Baxter International Stock Price, News & Analysis (NYSE:BAX)

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, July 16th. Shareholders of record on Friday, August 30th will be given a dividend of $0.22 per share on Tuesday, October 1st. This represents a $0.88 annualized dividend and a yield of 1.00%. The ex-dividend date is Thursday, August 29th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has initiated a share repurchase plan on Tuesday, November 13th 2018, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 6.1% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings data on Thursday, July, 25th. The medical instruments supplier reported $0.89 EPS for the quarter, beating the consensus estimate of $0.81 by $0.08. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The firm's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Baxter International.

Baxter International will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Baxter International updated its FY19 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $3.34-3.40 for the period, compared to the Thomson Reuters consensus estimate of $3.33. The company issued revenue guidance of $11.24-11.35 billion, compared to the consensus revenue estimate of $11.23 billion.

16 Wall Street analysts have issued 12 month price objectives for Baxter International's shares. Their predictions range from $70.00 to $109.00. On average, they anticipate Baxter International's share price to reach $87.20 in the next twelve months. This suggests that the stock has a possible downside of 0.9%. View Analyst Price Targets for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Media coverage about BAX stock has trended somewhat positive recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Baxter International.

Baxter International saw a increase in short interest in September. As of September 30th, there was short interest totalling 6,470,000 shares, an increase of 32.6% from the August 30th total of 4,880,000 shares. Based on an average trading volume of 2,380,000 shares, the short-interest ratio is presently 2.7 days. Approximately 1.3% of the shares of the stock are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hologic (HOLX), Steris (STE), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Johnson & Johnson (JNJ), Honeywell International (HON), Chipotle Mexican Grill (CMG), Micron Technology (MU), Cisco Systems (CSCO), Pfizer (PFE) and Verizon Communications (VZ).

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional investors include Robeco Institutional Asset Management B.V. (0.36%), Calamos Advisors LLC (0.19%), Rhumbline Advisers (0.18%), Locust Wood Capital Advisers LLC (0.08%), State of New Jersey Common Pension Fund D (0.08%) and Gateway Investment Advisers LLC (0.06%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Alberta Investment Management Corp, Gateway Investment Advisers LLC, Virginia Retirement Systems ET AL, John G Ullman & Associates Inc., Envestnet Asset Management Inc., Robeco Institutional Asset Management B.V. and Decatur Capital Management Inc.. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue, Varma Mutual Pension Insurance Co, Meeder Asset Management Inc., Calamos Advisors LLC, TIAA FSB, West Branch Capital LLC and Rhumbline Advisers. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $87.95.

Baxter International has a market capitalization of $44.90 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]